ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1165408
Boston, MA
Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$118,990,703
+$79,819,315 QoQ
Shares Held
6,424,984
+153.6% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $249,338,861 across 6 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (47.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
6,424,984 | $118,990,703 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
3,560,764 | $49,494,619 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
1,443,688 | $34,547,453 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
346,755 | $26,301,366 | |
| 5 | VTRS |
Viatris Inc
|
833,436 | $11,259,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
500,000 | $8,745,000 |
All Filings in TAK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,990,703 | 6,424,984 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $39,171,388 | 2,533,725 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,049,052 | 3,433,023 | Shares | Sole | 2025-05-15 | |
| 2021-06-30 | $4,207,500 | 250,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||